Keyphrases
Protein Kinase
100%
Cisplatin Resistance
100%
Cisplatin Sensitivity
100%
Bryostatin
100%
Human Cervical Carcinoma Cell
100%
HeLa
43%
Cisplatin-induced
25%
Phorbol 12
25%
Induced Cell Death
18%
Knockdown
12%
Small Interfering RNA (siRNA)
12%
Anti-apoptotic Proteins
12%
Cisplatin
12%
Induced Apoptosis
6%
Hypodiploidy
6%
Clinical Trials
6%
Cell Death
6%
Concentration-response
6%
HeLa Cells
6%
Complex Regulations
6%
Maximal Effect
6%
Annexin V
6%
Flow Cytometer
6%
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium Bromide
6%
MTT Assay
6%
Activation Status
6%
C-level
6%
Cisplatin Sensitization
6%
Binding Analysis
6%
Dye-binding Assay
6%
Unique Proteins
6%
Pharmacology, Toxicology and Pharmaceutical Science
Protein Kinase C
100%
Cisplatin
100%
Bryostatin 1
100%
Uterine Cervix Carcinoma
100%
Phorbol 12,13-dibutyrate
26%
Small Interfering RNA
13%
Clinical Trial
6%
Antiapoptotic
6%
Lipocortin 5
6%
3 (4,5 Dimethyl 2 Thiazolyl) 2,5 Diphenyltetrazolium Bromide
6%
Protein Kinase C Activator
6%
Neuroscience
Protein Kinase C
100%
Cisplatin
100%
Bryostatin
100%
Phorbol
25%
Cell Death
25%
Small Interfering RNA
12%
Lipocortin 5
6%
MTT Assay
6%
Biochemistry, Genetics and Molecular Biology
Protein Kinase C
100%
Cisplatin
100%
Downregulation
37%
Cell Death
25%
Small Interfering RNA
12%
Sensitization
12%
Clinical Trial
6%
MTT Assay
6%
Concentration Response
6%
Lipocortin
6%
Immunology and Microbiology
Carcinoma Cell
100%
Bryostatin 1
100%
Downregulation
46%
Cell Death
30%
Sensitization
15%
Concentration Response
7%